(0.04%) 5 310.37 points
(0.09%) 39 946 points
(-0.01%) 16 741 points
(0.84%) $79.29
(3.06%) $2.49
(-0.43%) $2 384.70
(0.44%) $29.86
(-0.17%) $1 068.30
(0.17%) $0.920
(0.32%) $10.70
(0.09%) $0.789
(0.25%) $90.91
@ $4.87
Issued: 9 Feb 2024 @ 10:05
Return: 2.63%
Previous signal: Feb 7 - 14:34
Previous signal:
Return: 3.99 %
Live Chart Being Loaded With Signals
Monte Rosa Therapeutics, Inc., a biopharmaceutical company, engages in the development of novel small molecule precision medicines that employ the body's natural mechanisms to selectively degrade therapeutically relevant proteins...
Stats | |
---|---|
Today's Volume | 633 468 |
Average Volume | 137 218 |
Market Cap | 252.56M |
EPS | $0 ( 2024-05-09 ) |
Next earnings date | ( $-0.580 ) 2024-08-08 |
Last Dividend | $0 ( N/A ) |
Next Dividend | $0 ( N/A ) |
P/E | -1.990 |
ATR14 | $0.0150 (0.30%) |
Date | Person | Action | Amount | type |
---|---|---|---|---|
2024-01-02 | Warmuth Markus | Buy | 346 000 | Stock Option (Right to Buy) |
2024-01-02 | Wallace Owen B. | Buy | 119 000 | Stock Option (Right to Buy) |
2024-01-02 | Jones Jullian G | Buy | 79 000 | Stock Option (Right to Buy) |
2024-01-02 | Janku Filip | Buy | 121 000 | Stock Option (Right to Buy) |
2024-01-02 | Nickson Philip | Buy | 109 000 | Stock Option (Right to Buy) |
INSIDER POWER |
---|
92.59 |
Last 98 transactions |
Buy: 57 206 836 | Sell: 164 598 288 |
Volume Correlation
Monte Rosa Therapeutics, Correlation
10 Most Positive Correlations |
---|
10 Most Negative Correlations |
---|
Did You Know?
Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).
Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.
Monte Rosa Therapeutics, Correlation - Currency/Commodity
Monte Rosa Therapeutics, Financials
Annual | 2023 |
Revenue: | $0 |
Gross Profit: | $-6.22M (0.00 %) |
EPS: | $-2.63 |
FY | 2023 |
Revenue: | $0 |
Gross Profit: | $-6.22M (0.00 %) |
EPS: | $-2.63 |
FY | 2022 |
Revenue: | $0 |
Gross Profit: | $-8.56M (0.00 %) |
EPS: | $-2.22 |
FY | 2021 |
Revenue: | $0.00 |
Gross Profit: | $0.00 (0.00 %) |
EPS: | $-6.64 |
Financial Reports:
No articles found.
Contract Name | Last Trade Date (EDT) | Strike | Last Price | Bid | Ask | Change | % Change | Volume | Open Interest | Implied Volatility | Strike Date |
---|---|---|---|---|---|---|---|---|---|---|---|
No data available |
Contract Name | Last Trade Date (EDT) | Strike | Last Price | Bid | Ask | Change | % Change | Volume | Open Interest | Implied Volatility | Strike Date |
---|---|---|---|---|---|---|---|---|---|---|---|
No data available |
Monte Rosa Therapeutics,
Monte Rosa Therapeutics, Inc., a biopharmaceutical company, engages in the development of novel small molecule precision medicines that employ the body's natural mechanisms to selectively degrade therapeutically relevant proteins. It develops an oral molecular glue degrader for GSPT1, a translational termination factor and degron-containing protein for the treatment of Myc-driven cancers. The company also develops CDK2 to treat ovarian, uterine, and breast cancers; NEK7 for the treatment of inflammatory diseases, such as Crohn's disease, neurodegenerative disease, diabetes, and liver disease; VAV1, a target protein for autoimmune diseases; and BCL11A, a therapeutically-relevant protein in hemoglobinopathies. Monte Rosa Therapeutics, Inc. was incorporated in 2019 and is headquartered in Boston, Massachusetts.
About Live Signals
The live signals presented on this page help determine when to BUY or SELL NA. The signals have upwards of a 1-minute delay; like all market signals, there is a chance for error or mistakes.
The live trading signals are not definite, and getagraph.com hold no responsibility for any action taken upon these signals, as described in the Terms of Use. The signals are based on a wide range of technical analysis indicators